FDA Inspection 633558 — Haw Par Healthcare Limited

Haw Par Healthcare Limited — FEI 3001432470

The FDA completed an inspection of Haw Par Healthcare Limited on October 29, 2009 in Singapore. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
October 29, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Postmarket Surv. and Epidemiology
Location
Singapore (Singapore)